isoniazid has been researched along with sulfasalazine in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (33.33) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 10 (41.67) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Palmas, S | 1 |
Drayer, DE; Reidenberg, MM | 1 |
Actis, G; Alberico, G; Genovesio, L; Goitre, M; Mele, M; Molinaro, GC; Puiatti, P; Salvai, M | 1 |
Celle, G; Gesu, GP; Picciotto, A; Schito, GC; Testa, R; Varagona, G | 1 |
Biarese, V; Cargnino, M; Lerda, R; Lovisetto, P; Mairano, D; Marchi, L | 1 |
Clark, DW | 1 |
Bourel, M; Lenoir, P; Pawlotsky, Y; Simon, M | 1 |
Skakun, NP | 1 |
Preisig, R | 1 |
Geusens, P; Landewe, S; Van Wijngaerden, E; Vanhoof, J | 1 |
Aklillu, E; Altman, RB; Boukouvala, S; Hein, DW; Klein, TE; McDonagh, EM | 1 |
Asgharzadeh, F; Davoodi, J; Khazaei, M; Nazari, E; Rezaie, S; Soleimanpour, S; Yaghoubi, A | 1 |
6 review(s) available for isoniazid and sulfasalazine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Therapy of ulcerative colitis].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Isoniazid; Psychotherapy; Sulfasalazine; Tranquilizing Agents | 1977 |
[Drug-induced lupus].
Topics: Acetylation; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Anticonvulsants; B-Lymphocytes; Diagnosis, Differential; HLA Antigens; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Lymphocyte Activation; Penicillamine; Procainamide; Sulfasalazine; T-Lymphocytes, Regulatory | 1985 |
Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Topics: Acetylation; Anticonvulsants; Antidepressive Agents, Tricyclic; Debrisoquin; Disease; Drug Interactions; Genetic Variation; Humans; Hydralazine; Isoniazid; Oxidation-Reduction; Pharmaceutical Preparations; Phenelzine; Phenotype; Procainamide; Racial Groups; Sparteine; Sulfasalazine | 1985 |
[Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
Topics: Acetylation; Acetyltransferases; Dapsone; Humans; Hydralazine; Inactivation, Metabolic; Isoniazid; Kinetics; Liver; Pharmaceutical Preparations; Phenotype; Procainamide; Sulfamethazine; Sulfasalazine | 1982 |
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
Topics: Alleles; Arylamine N-Acetyltransferase; Caffeine; Gene Expression Profiling; Genomics; Genotype; Humans; Hydralazine; Isoenzymes; Isoniazid; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Sulfamethoxazole; Sulfasalazine; Xenobiotics | 2014 |
18 other study(ies) available for isoniazid and sulfasalazine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Clinical consequences of polymorphic acetylation of basic drugs.
Topics: Acetylation; Antibodies, Antinuclear; Biotransformation; Chemical and Drug Induced Liver Injury; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Pharmaceutical Preparations; Phenelzine; Phenotype; Polymorphism, Genetic; Procainamide; Sulfasalazine | 1977 |
Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients.
Topics: Adult; Colitis, Ulcerative; Ethambutol; Humans; Isoniazid; Prednisone; Rifampin; Sulfasalazine; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1990 |
Antimycobacterial chemotherapy in inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium; Rifampin; Sulfasalazine | 1989 |
[Ulcero-hemorrhagic rectocolotis and Fiessinger-Leroy-Reiter syndrome with inclusion cells].
Topics: Adult; Arthritis, Reactive; Chloramphenicol; Colistin; Colitis; Cytomegalovirus Infections; Humans; Isoniazid; Male; Methylprednisolone; Penicillins; Sulfasalazine | 1968 |
[Pharmacogenetics: light in the darkness of drug toxicity].
Topics: Acetylation; Biological Availability; Drug Combinations; Glucosamine; Humans; Hydralazine; Hydroxylation; Isoniazid; Liver; Pharmacogenetics; Receptors, Drug; Sulfasalazine | 1982 |
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Drug Interactions; Humans; Isoniazid; Methotrexate; Middle Aged; Sulfasalazine; Tuberculosis; Tumor Necrosis Factor-alpha | 2003 |
Therapeutic effect of an anti-tuberculosis agent, isoniazid, and its nano-isoform in ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antitubercular Agents; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Combinations; Humans; Intestinal Mucosa; Isoniazid; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Sulfasalazine | 2021 |